Wu Zhiguo, Fang Yiru
Division of Mood Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shanghai Arch Psychiatry. 2014 Aug;26(4):227-31. doi: 10.3969/j.issn.1002-0829.2014.04.006.
Comorbid anxiety is common in patients with depressive disorders. It complicates the clinical presentation of depressive disorders and can contribute to treatment resistance. Clinicians can assess the degree of overlap between depressive and anxiety symptoms either by measuring the severity of anxiety symptoms in individuals who meet diagnostic criteria for depression or by determining whether or not an individual with depression simultaneously meets criteria for an anxiety disorder. However, multiple factors in the Chinese clinical setting make it difficult to accurately assess patients with comorbid conditions. The resultant under-diagnosis of comorbid depression and anxiety - the most common type of comorbid psychiatric condition in China - seriously diminishes the effectiveness of treatments for common mental disorders in the country. We argue that the widespread use of valid and reliable dimensional assessment tools in Chinese clinical settings will help improve the diagnosis and treatment of the many individuals who have concurrent depressive and anxiety symptoms.
共病焦虑在抑郁症患者中很常见。它使抑郁症的临床表现复杂化,并可能导致治疗抵抗。临床医生可以通过测量符合抑郁症诊断标准的个体的焦虑症状严重程度,或通过确定抑郁症患者是否同时符合焦虑症标准,来评估抑郁和焦虑症状之间的重叠程度。然而,中国临床环境中的多种因素使得难以准确评估共病患者。共病抑郁和焦虑(中国最常见的共病精神疾病类型)的诊断不足,严重降低了该国常见精神障碍的治疗效果。我们认为,在中国临床环境中广泛使用有效且可靠的维度评估工具,将有助于改善许多有并发抑郁和焦虑症状个体的诊断和治疗。